Are you Dr. Damaraju?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 94 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Texan Trl
Ste 300
Corpus Christi, TX 78411Phone+1 361-887-2900Fax+1 361-887-0942
Summary
- Dr. Srikanth Damaraju, MD is a cardiologist in Corpus Christi, Texas. He is currently licensed to practice medicine in Texas and Pennsylvania. He is affiliated with Corpus Christi Medical Center, Post Acute Medical Specialty Hospital of Corpus Christi - North, and CHRISTUS Spohn Hospital Corpus Christi Memorial.
Education & Training
- Baylor College of MedicineFellowship, Cardiovascular Disease, 1996 - 1998
- Baylor College of MedicineResidency, Internal Medicine, 1993 - 1995
- SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 1992 - 1993
- Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 1992
Certifications & Licensure
- TX State Medical License 1997 - 2026
- PA State Medical License 1997 - 1998
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Geographical Differences in Cardiovascular Comorbidities and Outcomes of COVID-19 Hospitalized Patients in the USA.Efstratios Koutroumpakis, S. Shahrukh Hashmi, Christopher Powell, Mariya Fatakdawala, Jason Pang
Cardiology. 2021-04-26 - 4 citations"Covidsubo": Stress-Induced Cardiomyopathy by Novel Coronavirus Disease 2019.Efstratios Koutroumpakis, Travis Taylor, Srikanth Damaraju, Shamim Badruddin Mawji
Cardiology. 2020-09-28 - 18 citationsApolipoprotein ε4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplastySrikanth Damaraju, Qun Tao Yu, Faye Safavi, Ali J. Marian
The American Journal of Cardiology. 1995-06-01
Professional Memberships
- Fellow